Tanaka T
Clin Pediatr Endocrinol. 2022; 31(4):211-224.
PMID: 36405437
PMC: 9637418.
DOI: 10.1297/cpe.2022-0034.
Tanaka T
Clin Pediatr Endocrinol. 2022; 31(1):1-9.
PMID: 35002062
PMC: 8713065.
DOI: 10.1297/cpe.2021-0044.
Peden A, Suleiman S, Barria M
Front Aging Neurosci. 2021; 13:716452.
PMID: 34413769
PMC: 8368127.
DOI: 10.3389/fnagi.2021.716452.
Pritzkow S, Gorski D, Ramirez F, Soto C
Clin Microbiol Rev. 2021; 34(4):e0005919.
PMID: 34319151
PMC: 8404694.
DOI: 10.1128/CMR.00059-19.
Ritchie D, Barria M
Biomolecules. 2021; 11(2).
PMID: 33540845
PMC: 7912988.
DOI: 10.3390/biom11020207.
Retinal correlates of neurological disorders.
Yap T, Balendra S, T Almonte M, Cordeiro M
Ther Adv Chronic Dis. 2019; 10:2040622319882205.
PMID: 31832125
PMC: 6887800.
DOI: 10.1177/2040622319882205.
Oral and intravenous transmission of α-synuclein fibrils to mice.
Lohmann S, Bernis M, Tachu B, Ziemski A, Grigoletto J, Tamguney G
Acta Neuropathol. 2019; 138(4):515-533.
PMID: 31230104
PMC: 6778172.
DOI: 10.1007/s00401-019-02037-5.
The Use and Abuse of Human Growth Hormone in Sports.
Siebert D, Rao A
Sports Health. 2018; 10(5):419-426.
PMID: 29932857
PMC: 6116101.
DOI: 10.1177/1941738118782688.
Amyloid-β accumulation in the CNS in human growth hormone recipients in the UK.
Ritchie D, Adlard P, Peden A, Lowrie S, Le Grice M, Burns K
Acta Neuropathol. 2017; 134(2):221-240.
PMID: 28349199
PMC: 5508038.
DOI: 10.1007/s00401-017-1703-0.
Biopharmaceuticals from microorganisms: from production to purification.
Jozala A, Geraldes D, Tundisi L, Feitosa V, Breyer C, Cardoso S
Braz J Microbiol. 2016; 47 Suppl 1:51-63.
PMID: 27838289
PMC: 5156500.
DOI: 10.1016/j.bjm.2016.10.007.
UK Iatrogenic Creutzfeldt-Jakob disease: investigating human prion transmission across genotypic barriers using human tissue-based and molecular approaches.
Ritchie D, Barria M, Peden A, Yull H, Kirkpatrick J, Adlard P
Acta Neuropathol. 2016; 133(4):579-595.
PMID: 27812793
PMC: 5348565.
DOI: 10.1007/s00401-016-1638-x.
Diagnosing Sporadic Creutzfeldt-Jakob Disease by the Detection of Abnormal Prion Protein in Patient Urine.
Luk C, Jones S, Thomas C, Fox N, Mok T, Mead S
JAMA Neurol. 2016; 73(12):1454-1460.
PMID: 27699415
PMC: 5701732.
DOI: 10.1001/jamaneurol.2016.3733.
Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years.
Rudge P, Jaunmuktane Z, Adlard P, Bjurstrom N, Caine D, Lowe J
Brain. 2015; 138(Pt 11):3386-99.
PMID: 26268531
PMC: 4620512.
DOI: 10.1093/brain/awv235.
Ethics in prion disease.
Bechtel K, Geschwind M
Prog Neurobiol. 2013; 110:29-44.
PMID: 23906487
PMC: 3818451.
DOI: 10.1016/j.pneurobio.2013.07.001.
Crucial role for prion protein membrane anchoring in the neuroinvasion and neural spread of prion infection.
Klingeborn M, Race B, Meade-White K, Rosenke R, Striebel J, Chesebro B
J Virol. 2010; 85(4):1484-94.
PMID: 21123371
PMC: 3028874.
DOI: 10.1128/JVI.02167-10.
The neuropsychology of variant CJD: a comparative study with inherited and sporadic forms of prion disease.
Cordery R, Alner K, Cipolotti L, Ron M, Kennedy A, Collinge J
J Neurol Neurosurg Psychiatry. 2005; 76(3):330-6.
PMID: 15716521
PMC: 1739530.
DOI: 10.1136/jnnp.2003.030320.
Early cognitive decline in Creutzfeldt-Jakob disease associated with human growth hormone treatment.
Cordery R, Hall M, Cipolotti L, Al-Sarraj S, ODonovan D, Davidson L
J Neurol Neurosurg Psychiatry. 2003; 74(10):1412-6.
PMID: 14570836
PMC: 1757404.
DOI: 10.1136/jnnp.74.10.1412.
Growth of children with Langerhans cell histiocytosis.
van den Hoek A, Karstens A, Egeler R, Hahlen K
Eur J Pediatr. 1995; 154(10):822-5.
PMID: 8529681
DOI: 10.1007/BF01959790.
Prions and related neurological diseases.
Pocchiari M
Mol Aspects Med. 1994; 15(3):195-291.
PMID: 7968312
PMC: 7133568.
DOI: 10.1016/0098-2997(94)90042-6.
Who needs growth hormone?.
Stirling H, Kelnar C
J R Soc Med. 1994; 87(9):497-8.
PMID: 7932448
PMC: 1294757.
DOI: 10.1177/014107689408700901.